|
3890
|
(R)-(-)-PD123319 ditrifluoroacetate (Optically pure)
|
Opposite enantiomer of PD123319 ditrifluoroacetate |
€140.00 |
|
4030
|
AOH1996
|
Orally available PCNA inhibitor |
€140.00 |
|
4058
|
Atrasentan
|
Highly potent, selective, and orally active endothelin-A (ETA) antagonist |
€130.00 |
|
4074
|
AZ5104
|
EGFR inhibitor |
Inquire |
|
3936
|
Bisindolylmaleimide I
|
Potent and selective PKC inhibitor |
€120.00 |
|
3846
|
C25-140
|
First-in-class TRAF6–Ubc13 inhibitor |
€160.00 |
|
4073
|
CYC-116
|
Aurora kinases A & B and VEGFR2 inhibitor |
Inquire |
|
4072
|
Doxorubicin hydrochloride
|
A cytotoxic anthracycline antibiotic |
Inquire |
|
3817
|
Eflornithine hydrochloride
|
Selective, irreversible ODC inhibitor |
€80.00 |
|
4095
|
Elacestrant dihydrochloride
|
Orally bioavailable selective estrogen receptor degrader (SERD) |
€220.00 |
|
4048
|
Iguratimod
|
Orally active DMARD |
€70.00 |
|
3925
|
IHCH-7079
|
5-HT2A receptor arrestin-biased agonist |
€150.00 |
|
3959
|
JG-2016
|
First inhibitor of the HAT1 enzyme complex |
€140.00 |
|
3816
|
N-Carbamyl-L-glutamic acid
|
CPS1 activator |
€80.00 |
|
4045
|
Nimustine hydrochloride
|
Water-soluble DNA alkylating agent |
€90.00 |
|
4064
|
Paltusotine dihydrochloride
|
Potent, selective, and orally bioavailable SST2 agonist |
€160.00 |
|
4076
|
Pyridostatin hydrochloride
|
G-quadruplex DNA stabilizing agent |
Inquire |
|
4075
|
Serabelisib
|
PI3K p110α isoform specific inhibitor |
Inquire |
|
4050
|
STL427944
|
Selective FOXM1 inhibitor |
€130.00 |
|
3678
|
UNC7467
|
Potent IP6K inhibitor |
€130.00 |
|
4077
|
Varespladib
|
sPLA2 inhibitor |
Inquire |